-
1
المؤلفون: Cheryl Enger, Libby Horter, Nina Sahlertz Kristiansen, Stefan de Vogel, Kelesitse Phiri, Brandon T. Suehs, Jesper Hallas, Alejandro Arana, Marie Linder, Ingvild Odsbu, Yihua Xu, Andrea V. Margulis, Kwame Appenteng, John D. Seeger, Morten Olesen, Veena Hoffman, Susana Perez-Gutthann
المصدر: Hoffman, V, Hallas, J, Linder, M, Margulis, A, Suehs, B T, Arana, A, Phiri, K, Enger, C, Horter, L, Odsbu, I, Olesen, M, Perez-Gutthann, S, Xu, Y, Kristiansen, N S, Appenteng, K, de Vogel, S, Seeger, J D & the mirabegron PMR-PASS study group 2021, ' Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder : Findings from a Non-Interventional, Multinational, Cohort Study ', Drug Safety, vol. 44, no. 8, pp. 899-915 . https://doi.org/10.1007/s40264-021-01095-7
Drug Safetyمصطلحات موضوعية: Male, medicine.medical_specialty, Population, Muscarinic Antagonists, Toxicology, Cohort Studies, Risk Factors, Internal medicine, medicine, Humans, Pharmacology (medical), Original Research Article, education, Stroke, Aged, Pharmacology, education.field_of_study, Proportional hazards model, business.industry, Urinary Bladder, Overactive, Hazard ratio, medicine.disease, Thiazoles, Treatment Outcome, Overactive bladder, Cardiovascular Diseases, Heart Disease Risk Factors, Acetanilides, Female, Treatments for overactive bladder, Mirabegron, business, medicine.drug, Cohort study
وصف الملف: application/pdf
-
2
المصدر: Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacologyمصطلحات موضوعية: Cannabinoid receptor, Mini Review, Central nervous system, 030232 urology & nephrology, bladder dysfunction, Sensory system, RM1-950, urologic and male genital diseases, 03 medical and health sciences, 0302 clinical medicine, medicine, Cannabinoid receptor type 2, Pharmacology (medical), Urothelium, endocannabinoids, Pharmacology, business.industry, medicine.disease, Endocannabinoid system, bladder afferents, medicine.anatomical_structure, Overactive bladder, painful bladder syndrome, lipids (amino acids, peptides, and proteins), overactive bladder, Therapeutics. Pharmacology, Treatments for overactive bladder, business, Neuroscience, 030217 neurology & neurosurgery
-
3
المؤلفون: John D. Seeger, Marie Linder, Veena Hoffman, Alejandro Arana, Shahram Bahmanyar, Susana Perez-Gutthann, Jesper Hallas, Libby Horter, Brandon T. Suehs, Stefan de Vogel, Kelesitse Phiri, Nina Sahlertz Kristiansen, Andrea V. Margulis, Ingvild Odsbu, Kwame Appenteng, Cheryl Enger, Morten Olesen
المصدر: Phiri, K, Hallas, J, Linder, M, Margulis, A, Suehs, B, Arana, A, Bahmanyar, S, Hoffman, V, Enger, C, Horter, L, Odsbu, I, Olesen, M, Perez-Gutthann, S, Kristiansen, N S, Appenteng, K, de Vogel, S & Seeger, J 2021, ' A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder ', Current Medical Research and Opinion, vol. 37, no. 5, pp. 867-877 . https://doi.org/10.1080/03007995.2021.1891035
the Mirabegron PMR-PASS study group 2021, ' A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder ', Current Medical Research and Opinion . https://doi.org/10.1080/03007995.2021.1891035مصطلحات موضوعية: Male, medicine.medical_specialty, Urology, neoplasms, overactive, Muscarinic Antagonists, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, Neoplasms, medicine, Humans, In patient, 030212 general & internal medicine, antimuscarinics, Urinary bladder, business.industry, Urinary Bladder, Overactive, Incidence (epidemiology), Cancer, General Medicine, medicine.disease, PASS, mirabegron, Thiazoles, medicine.anatomical_structure, Treatment Outcome, Urological Agents, Acetanilides, Female, Treatments for overactive bladder, Mirabegron, business, medicine.drug
وصف الملف: application/pdf
-
4
المؤلفون: Christopher P. Dall, Tatevik Broutian, Tasha Posid, Alicia Scimeca, Fara F. Bellows, Catherine Hudson, Kristin M. Ebert, Andrew F. Hundley, Ketul K. Shah, Matthew T. Harbrecht
المصدر: Canadian Urological Association Journal. 15
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Urology, MEDLINE, medicine.disease, Patient counselling, Oncology, Overactive bladder, Chart review, Internal medicine, medicine, Multiple treatments, Initial treatment, Treatments for overactive bladder, business, Patient comfort
-
5
المؤلفون: John D. Seeger, Stefan de Vogel, Andrea V. Margulis, Susana Perez Gutthann, Jesper Hallas, Kwame Appenteng, Brandon T. Suehs, Alejandro Arana, Morten S. Olesen, Nina Sahlertz Kristiansen, Cheryl Enger, Libby Horter, Veena Hoffman, Yihua Xu, Ingvild Odsbu, Marie Linder
المصدر: Circulation. 142
مصطلحات موضوعية: Agonist, medicine.medical_specialty, business.industry, medicine.drug_class, Placebo, medicine.disease, Clinical trial, Blood pressure, Physiology (medical), Internal medicine, medicine, Cardiology, Myocardial infarction, Treatments for overactive bladder, Cardiology and Cardiovascular Medicine, Mirabegron, business, Stroke, medicine.drug
-
6
المؤلفون: Zuha Imtiyaz, Mei Hsien Lee, Lih Lian Chen, Chin Hsien Chang, Chih Chun Ke, Hui I. Chen, Yuh-Chiang Shen
المصدر: Phytomedicine : international journal of phytotherapy and phytopharmacology. 80
مصطلحات موضوعية: Male, medicine.medical_specialty, Cinnamomum zeylanicum, Placebo-controlled study, Pharmaceutical Science, Placebo, law.invention, Placebos, 03 medical and health sciences, symbols.namesake, 0302 clinical medicine, Randomized controlled trial, Double-Blind Method, law, Internal medicine, Drug Discovery, medicine, Clinical endpoint, Humans, Adverse effect, Fisher's exact test, 030304 developmental biology, Aged, Pharmacology, 0303 health sciences, business.industry, Urinary Bladder, Overactive, Middle Aged, medicine.disease, Treatment Outcome, Complementary and alternative medicine, Overactive bladder, 030220 oncology & carcinogenesis, symbols, Molecular Medicine, Female, Treatments for overactive bladder, business, Acupuncture Points
-
7
المؤلفون: Norifumi Sawada
المصدر: International journal of urology : official journal of the Japanese Urological AssociationReferences. 27(4)
مصطلحات موضوعية: medicine.medical_specialty, Urinary bladder, medicine.anatomical_structure, business.industry, Urinary Bladder, Overactive, Urology, MEDLINE, medicine, Humans, Treatments for overactive bladder, business
-
8
المؤلفون: Katarina Ivana Tudor, Juliana Ochulor, Mahreen Pakzad, Martina D. Liechti, Jai Seth, Jalesh N. Panicker, Collette Haslam, Gwen Gonzales, Zoe Fox
المصدر: Clinical Autonomic Research. 30:61-67
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Neurology, Urology, Neurological disorder, 030204 cardiovascular system & hematology, Transcutaneous electrical nerve stimulation, law.invention, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Quality of life, Lower urinary tract symptoms, law, medicine, Humans, Percutaneous tibial nerve stimulation, Aged, Retrospective Studies, Urinary Bladder, Overactive, Endocrine and Autonomic Systems, business.industry, Middle Aged, medicine.disease, Treatment Outcome, Urinary Incontinence, Overactive bladder, Transcutaneous Electric Nerve Stimulation, Female, Neurology (clinical), Tibial Nerve, Treatments for overactive bladder, business, 030217 neurology & neurosurgery
-
9
المؤلفون: Brigitte Schurch, Tom Marcelissen, Christopher H. Fry, Mario Averbeck, Arun Sahai, Sachin Malde, Alex Digesu
المصدر: Malde, S, Fry, C, Schurch, B, Marcelissen, T, Averbeck, M, Digesu, A & Sahai, A 2018, ' What is the exact working mechanism of botulinum toxin A and sacral neuromodulation in the treatment of overactive bladder / detrusor overactivity? ICI-RS 2017 ', Neurourology and Urodynamics, vol. 37, no. S4, pp. S108-S116 . https://doi.org/10.1002/nau.23552
مصطلحات موضوعية: 030232 urology & nephrology, urologic and male genital diseases, Botulinum toxin a, sacral neuromodulation, detrusor overactivity, 0302 clinical medicine, interstim, SPINAL-CORD-INJURY, Botulinum Toxins, Type A, Spinal cord injury, media_common, BLADDER UROTHELIAL CELLS, NEUROMODULATION, Botox, WOMEN, Botulinum toxin, female genital diseases and pregnancy complications, Neuromuscular Agents, Overactive bladder, INCONTINENCE, 030220 oncology & carcinogenesis, Treatments for overactive bladder, urodynamics, medicine.drug, medicine.medical_specialty, Urology, media_common.quotation_subject, Urination, Electric Stimulation Therapy, 03 medical and health sciences, NEUROGENIC DETRUSOR OVERACTIVITY, OnabotulinumtoxinA, medicine, Animals, Humans, botulinum toxin, Urothelium, INHIBITS ATP RELEASE, Urinary Bladder, Overactive, business.industry, LOWER URINARY-TRACT, medicine.disease, onabotulinumtoxinA, Sacral nerve stimulation, Interstim, overactive bladder, sacral nerve stimulation, Neurology (clinical), URGENCY, business, mechanism of action
وصف الملف: application/pdf
-
10
المؤلفون: Sue Ross, Magali Robert
المصدر: Journal of Obstetrics and Gynaecology Canada. 40:e119-e125
مصطلحات موضوعية: Stress incontinence, medicine.medical_specialty, 030219 obstetrics & reproductive medicine, Pelvic floor, business.industry, medicine.medical_treatment, Psychological intervention, Obstetrics and Gynecology, Urinary incontinence, Cochrane Library, Biofeedback, medicine.disease, body regions, 03 medical and health sciences, 0302 clinical medicine, medicine.anatomical_structure, Overactive bladder, medicine, Physical therapy, 030212 general & internal medicine, medicine.symptom, Treatments for overactive bladder, business
-
11
المؤلفون: Roxana Geoffrion
المصدر: Journal of Obstetrics and Gynaecology Canada. 39:1221-1229
مصطلحات موضوعية: medicine.medical_specialty, 030232 urology & nephrology, Muscarinic Antagonists, law.invention, 03 medical and health sciences, 0302 clinical medicine, Pharmacotherapy, Randomized controlled trial, law, Fesoterodine, Humans, Medicine, 030212 general & internal medicine, Benzhydryl Compounds, Intensive care medicine, Gynecology, Solifenacin, Urinary Bladder, Overactive, business.industry, Obstetrics and Gynecology, medicine.disease, Thiazoles, Systematic review, Overactive bladder, Urological Agents, Acetanilides, Drug Therapy, Combination, Female, Treatments for overactive bladder, business, Mirabegron, medicine.drug
-
12
المؤلفون: Steve J. Hodges, Austin G. Hester
المصدر: Current Bladder Dysfunction Reports. 12:229-232
مصطلحات موضوعية: medicine.medical_specialty, Side effect, Geriatrics gerontology, business.industry, 030232 urology & nephrology, Bladder capacity, urologic and male genital diseases, medicine.disease, Biochemistry, 03 medical and health sciences, Bladder outlet obstruction, 0302 clinical medicine, Overactive bladder, 030220 oncology & carcinogenesis, medicine, Treatments for overactive bladder, Intensive care medicine, Mirabegron, business, Molecular Biology, Pediatric population, medicine.drug
-
13
المؤلفون: Anja Huion, Karel Everaert, Mirko Petrovic, Marie-Astrid Denys, Dries F. Benoit, Veerle Decalf
المصدر: Drugs & Aging. 34:615-623
مصطلحات موضوعية: Male, medicine.medical_specialty, Constipation, Drug-Related Side Effects and Adverse Reactions, Side effect, 030232 urology & nephrology, Administration, Oral, Subgroup analysis, Muscarinic Antagonists, Choice Behavior, 03 medical and health sciences, 0302 clinical medicine, Blurred vision, Surveys and Questionnaires, Prevalence, medicine, Humans, Pharmacology (medical), 030212 general & internal medicine, Adverse effect, Aged, Gynecology, Urinary Bladder, Overactive, business.industry, Patient Preference, Cognition, medicine.disease, Logistic Models, Urinary Incontinence, Overactive bladder, Physical therapy, Female, Geriatrics and Gerontology, medicine.symptom, Treatments for overactive bladder, business
-
14
المؤلفون: Stefan de Vogel, Andrea V. Margulis, Alejandro Arana, Libby Horter, Susana Perez-Gutthann, Kwame Appenteng, Kelesitse Phiri, Shahram Bahmanyar, Jesper Hallas, Morten S. Olesen, Nina Sahlertz Kristiansen, John D. Seeger, Marie Linder, Cheryl Enger, Ingvild Odsbu, Brandon T. Suehs
المصدر: The Journal of Urology. 203:e910-e911
مصطلحات موضوعية: Agonist, medicine.medical_specialty, business.industry, medicine.drug_class, Urology, Cancer, medicine.disease, Overactive bladder, Medicine, Treatments for overactive bladder, business, Mirabegron, medicine.drug
-
15
المؤلفون: Martin C. Michel
مصطلحات موضوعية: medicine.medical_specialty, Urinary Bladder, Overactive, business.industry, Urology, 030232 urology & nephrology, 610 Medizin, Efficacy expectations, Overactive bladder syndrome, Approved drug, Review article, 03 medical and health sciences, 0302 clinical medicine, Tolerability, Drug development, 030220 oncology & carcinogenesis, 610 Medical sciences, medicine, Animals, Humans, Biomarker (medicine), Treatments for overactive bladder, Intensive care medicine, business
-
16
المؤلفون: Francisco J. Orejuela, Cedric K. Olivera, Sherif A. El-Nashar, Ethan M Balk, Shunaha Kim-Fine, Thomas L. Wheeler, Kate V. Meriwether, Miles Murphy, Brook McFadden, Danielle D. Antosh, Chi Chiung Grace Chen, Cara L. Grimes, Jon Gleason
المصدر: American Journal of Obstetrics and Gynecology. 215:34-57
مصطلحات موضوعية: medicine.medical_specialty, medicine.medical_treatment, 030232 urology & nephrology, Urinary incontinence, Biofeedback, 03 medical and health sciences, 0302 clinical medicine, Solabegron, medicine, Humans, Nocturia, 030219 obstetrics & reproductive medicine, medicine.diagnostic_test, Urinary Bladder, Overactive, business.industry, Obstetrics and Gynecology, medicine.disease, Overactive bladder, Physical therapy, Urodynamic testing, Female, medicine.symptom, Treatments for overactive bladder, business, Mirabegron, medicine.drug
-
17
المؤلفون: Alison Levy, Lara S. MacLachlan
المصدر: Contemporary Pharmacotherapy of Overactive Bladder ISBN: 9783319972640
مصطلحات موضوعية: medicine.medical_specialty, Overactive bladder, business.industry, Alternative therapy, Cohort, Medicine, Symptom control, Treatments for overactive bladder, business, medicine.disease, Intensive care medicine, Adverse effect
-
18
المؤلفون: Shingo Iino, Masayuki Kaneko, Mamoru Narukawa
المصدر: International urology and nephrology. 50(6)
مصطلحات موضوعية: medicine.medical_specialty, Time Factors, Endpoint Determination, Urology, media_common.quotation_subject, 030232 urology & nephrology, Urination, Disease, Urine, law.invention, 03 medical and health sciences, 0302 clinical medicine, Sex Factors, Randomized controlled trial, law, Internal medicine, medicine, Humans, media_common, Randomized Controlled Trials as Topic, business.industry, Urinary Bladder, Overactive, medicine.disease, Clinical trial, Systematic review, Treatment Outcome, Overactive bladder, Nephrology, 030220 oncology & carcinogenesis, Meta-analysis, Urological Agents, Treatments for overactive bladder, business
-
19
المؤلفون: Willem Jan Atsma, Alejandro Arana, Anton Pottegård, Andrea V. Margulis, Susana Perez-Gutthann, Cristina Varas-Lorenzo, Milbhor D’Silva, Jesper Hallas, Billy Franks, Nina Sahlertz Kristiansen
المصدر: Margulis, A V, Hallas, J, Pottegård, A, Kristiansen, N S, Atsma, W J, Franks, B, D’Silva, M, Varas-Lorenzo, C, Perez-Gutthann, S & Arana, A 2018, ' Comparison of cardiovascular events among treatments for overactive bladder : a Danish nationwide cohort study ', European Journal of Clinical Pharmacology, vol. 74, no. 2, pp. 193-199 . https://doi.org/10.1007/s00228-017-2359-3
مصطلحات موضوعية: Male, medicine.medical_specialty, Denmark, Muscarinic antagonists, 030232 urology & nephrology, Muscarinic Antagonists, Muscarinic Antagonists/adverse effects, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Fesoterodine, Medicine, Humans, Pharmacology (medical), 030212 general & internal medicine, Aged, Pharmacology, Solifenacin, Urinary Bladder, Overactive, business.industry, Pharmacoepidemiology, Incidence, Urinary bladder, overactive, General Medicine, medicine.disease, Cardiovascular Diseases/chemically induced, Denmark/epidemiology, Cardiovascular diseases, Overactive bladder, Cardiovascular Diseases, Urinary Bladder, Overactive/drug therapy, Female, Tolterodine, Treatments for overactive bladder, business, Mace, medicine.drug, Cohort study
-
20
المؤلفون: Roxana Geoffrion
المصدر: Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC. 40(1)
مصطلحات موضوعية: medicine.medical_specialty, medicine.drug_class, 030232 urology & nephrology, Vaginal estrogen, Cholinergic Antagonists, law.invention, 03 medical and health sciences, 0302 clinical medicine, Transdermal estrogen, Randomized controlled trial, law, Pregnancy, Internal medicine, medicine, Anticholinergic, Humans, 030212 general & internal medicine, Treatment Failure, Oxybutynin, Solifenacin, business.industry, Urinary Bladder, Overactive, Obstetrics and Gynecology, Estrogens, medicine.disease, Overactive bladder, Female, Treatments for overactive bladder, business, medicine.drug